ATE426806T1 - Verfahren zur prognose der wirksamkeit von chemotherapie - Google Patents

Verfahren zur prognose der wirksamkeit von chemotherapie

Info

Publication number
ATE426806T1
ATE426806T1 AT06001765T AT06001765T ATE426806T1 AT E426806 T1 ATE426806 T1 AT E426806T1 AT 06001765 T AT06001765 T AT 06001765T AT 06001765 T AT06001765 T AT 06001765T AT E426806 T1 ATE426806 T1 AT E426806T1
Authority
AT
Austria
Prior art keywords
predicting
effectiveness
comparing
chemotherapy
activity
Prior art date
Application number
AT06001765T
Other languages
English (en)
Inventor
Yasuhiro Torikoshi
Yuko Kawasaki
Satoshi Nakayama
Hideki Ishihara
Tomoko Matsushima
Original Assignee
Sysmex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sysmex Corp filed Critical Sysmex Corp
Application granted granted Critical
Publication of ATE426806T1 publication Critical patent/ATE426806T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06001765T 2005-01-31 2006-01-27 Verfahren zur prognose der wirksamkeit von chemotherapie ATE426806T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005022593 2005-01-31
JP2005158373 2005-05-31

Publications (1)

Publication Number Publication Date
ATE426806T1 true ATE426806T1 (de) 2009-04-15

Family

ID=36177637

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06001765T ATE426806T1 (de) 2005-01-31 2006-01-27 Verfahren zur prognose der wirksamkeit von chemotherapie

Country Status (4)

Country Link
US (1) US7957910B2 (de)
EP (1) EP1686377B1 (de)
AT (1) ATE426806T1 (de)
DE (1) DE602006005849D1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8921057B2 (en) * 2004-05-31 2014-12-30 Sysmex Corporation Method of assessing properties of mammalian cells, and method of diagnosing cancer using the same
CN102605066A (zh) * 2004-12-08 2012-07-25 安万特药物公司 测量对多西他赛抗药性或敏感性的方法
US7682785B2 (en) * 2005-06-30 2010-03-23 Sysmex Corporation Method for predicting effectiveness of chemotherapy using anticancer agent
JP2007259846A (ja) 2006-02-28 2007-10-11 Sysmex Corp 悪性腫瘍の性質の判定方法
JP5111902B2 (ja) * 2007-03-14 2013-01-09 シスメックス株式会社 癌の診断支援装置
JP5274808B2 (ja) 2007-10-02 2013-08-28 シスメックス株式会社 がんの診断支援システム
JP2009240238A (ja) * 2008-03-31 2009-10-22 Sysmex Corp アンスラサイクリン系抗がん剤に対するがん細胞の感受性の判定方法及び判定装置
JP2010057486A (ja) * 2008-09-02 2010-03-18 Sysmex Corp 化学療法に対するがん患者の応答の予測方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999042821A2 (en) * 1998-02-18 1999-08-26 Theryte Limited Treating cancer
GB2334578A (en) 1998-02-18 1999-08-25 Univ Liverpool Diagnosis of cancer involving assay of levels of cyclin-dependent kinase (CDK) isoenzymes
JP3923366B2 (ja) 2001-10-24 2007-05-30 財団法人癌研究会 細胞の抗癌剤感受性の判定法
JP2003304884A (ja) 2002-02-13 2003-10-28 Japan Found Cancer Res 抗がん剤の適合性予測方法
US7501257B2 (en) 2003-02-26 2009-03-10 Sysmex Corporation Molecular diagnostic method of a cancer tissue or a cancer cell
US8021831B2 (en) 2003-08-25 2011-09-20 Board Of Regents, The University Of Texas System Taxane chemosensitivity prediction test

Also Published As

Publication number Publication date
US7957910B2 (en) 2011-06-07
DE602006005849D1 (de) 2009-05-07
EP1686377B1 (de) 2009-03-25
US20060173632A1 (en) 2006-08-03
EP1686377A1 (de) 2006-08-02

Similar Documents

Publication Publication Date Title
DE602005016402D1 (de) Stabile lagerung von protein und stabile lagerung von nukleinsäure in wiedergewinnbarer form
DE602005025998D1 (de) Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs
WO2007019899A3 (en) Method for predicting the response to a treatment with a her dimerization inhibitor
WO2009070767A3 (en) Systemic instigation systems to study tumor growth or metastasis
EA200500053A1 (ru) Способы получения замещённых пиримидинов и производных пиримидинов в качестве ингибиторов протеинкиназ
EP1679964A4 (de) Zusammensetzungen mit bzw. verfahren zur verwendung von sirna-amphipathischen verbindungen und polykationen
DE602004018971D1 (de) Verfahren zur gewinnung von polyhydroxyalkanolaten ( phas ) aus zellbiomasse
ATE518966T1 (de) Systeme und verfahren zur bestimmung von übersprechungskoeffizienten in pcr und anderen datensets
ATE426806T1 (de) Verfahren zur prognose der wirksamkeit von chemotherapie
EP1800432A4 (de) Kryptographische stammfunktionen, fehlerkodierung und verfahren zur verbesserung von zufallszahlen unter verwendung von quasigruppen
WO2004103394A3 (en) Method and compositions for nerve regeneration
DE602005024964D1 (de) Verfahren zur beurteilung der malignität einer säuger-krebszelle
ATE411395T1 (de) Verfahren zur identifizierung und/oder validierung von rezeptortyrosinkinase-inhibitoren
DE602007004889D1 (de) Verfahren zur Einschätzung des Risikos maligner Tumorrezidive
ATE444949T1 (de) Verfahren zur herstellung von n-monoalkyl-beta- aminoalkoholen
ATE464056T1 (de) Verfahren zur aktivierung von nkt-zellen
Haussmann et al. Telomerase expression is differentially regulated in birds of differing life span
ATE531821T1 (de) Verfahren und vorrichtung zur beurteilung des vorliegens oder nichtvorliegens einer krebszelle
DE602004015291D1 (de) Verfahren zur bildung von vorgebildeten stabilisatorpolyolen
DE602004017884D1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
WO2007026355A3 (en) Modulators of cell migration and methods of identifying same
ATE352039T1 (de) Verfahren zur bestimmung der aktivität von thymidinkinase-1 und dessen verwendung
EP1348762A4 (de) Verfahren zur genexpressionsanalyse
ATE501252T1 (de) Verfahren zur inhibierung von tumorzellwachstum mit foxm1 sirns
ATE394749T1 (de) Verfahren zur benutzeridentifizierung mittels veränderter biometrischer eigenschaften und datenbank zur ausführung dieses verfahrens

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties